DIFFUSE INTRINSIC PONTINE GLIOMA
Clinical trials for DIFFUSE INTRINSIC PONTINE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE INTRINSIC PONTINE GLIOMA trials appear
Sign up with your email to follow new studies for DIFFUSE INTRINSIC PONTINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising targeted therapy takes on deadliest childhood brain cancers
Disease control Not yet recruitingThis study tests a drug called tovorafenib in children and young adults (ages 1 to 39) newly diagnosed with aggressive brain tumors (high-grade glioma or DIPG) that have specific genetic changes. The goal is to see if the drug can help patients live longer by targeting those gene…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
Engineered immune cells take on childhood brain cancer
Disease control Not yet recruitingThis early-phase study tests a new treatment for children and young adults with aggressive brain tumors called high-grade glioma and DIPG. The therapy uses the patient's own immune cells, modified to better find and attack the tumor. The main goals are to see if the treatment is …
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated May 26, 2026 12:04 UTC